Archived articles

Johns hopkins technology ventures

Tech ventures
Three teams receive grants from Bisciotti Foundation Translational Fund
Published March 10, 2022
Three research teams received grants from the Bisciotti Foundation Translational Fund to advance their commercially viable invention concepts
JHTV's billion dollar year
Published Sept 22, 2021
Startup companies founded at Johns Hopkins had a record-setting fiscal year, raising more than $1 billion in funding
Cancer research
Startup founders from Johns Hopkins aim to stop spread of cancer
Published July 28, 2021
AbMeta Therapeutics, launched by biologist and Provost Denis Wirtz, bioengineer Jamie Spangler, and clinician Elizabeth Jaffee, will combine years of pioneering research to create new drugs that target metastasis
Tech Ventures
Dyslexia Advocation wins $25K prize at Social Innovation Lab showcase
Published June 14, 2021
The company helps Black and other minority communities offset the costs of advocacy services, specialized tutoring, and neuropsychological evaluations for children with learning disabilities
Research funding
Bayer extends research agreement with Hopkins through 2024
Published May 6, 2021
The pharmaceuticals and life sciences company will continue its partnership with Johns Hopkins to provide funding to researchers in the Wilmer Eye Institute
Tech Ventures
Four Johns Hopkins discoveries head to commercial path
Published March 15, 2021
Four Johns Hopkins professors are pursuing commercial paths for their discoveries
Scaling up rapid saliva tests for COVID-19 antibodies
Published March 12, 2021
Microbiologist Christopher Heaney aims to increase production of saliva-based rapid tests for COVID-19 antibodies, tracking the virus' spread more quickly and frequently
Tech ventures
Sri Sarma wins inauguaral Pitch It On! competition
Published Nov 3, 2020
Competition concluded a year of Johns Hopkins Technology Ventures programming that aimed to support female innovators and inventors
Technology Ventures
Grants support proof-of-concept and validation studies of Johns Hopkins inventions
Published Sept 18, 2020
ePACStim device delivers targeted, customizable electric brain stimulation to treat neurological conditions; NanoTox provides localized, sustained release of neuromodulators like Botox for cosmetic and medical purposes
For the greater good
Published Fall 2020
For nearly a decade, the Johns Hopkins Social Innovation Lab has nurtured a generation of mission-driven companies / Johns Hopkins Magazine